CD27 Antibody Blocking peptide
CD27 Antibody Blocking peptide
Product Specifications
Product Name Alternative
CD27 antigen, CD27L receptor, T-cell activation antigen CD27, T14, Tumor necrosis factor receptor superfamily member 7, CD27, CD27, TNFRSF7
UniProt
P26842
Field of Research
Immunology & Inflammation; Cell Biology
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence was selected from the C-term region of CD27. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9420883-01 0.02 mg
Recombinant Clostridium botulinum Botulinum neurotoxin type A
Sign In for Pricing
View Details MBS9420883-02 0.1 mg
Recombinant Clostridium botulinum Botulinum neurotoxin type A
Sign In for Pricing
View Details MBS9420883-03 1 mg
Recombinant Clostridium botulinum Botulinum neurotoxin type A
Sign In for Pricing
View Details MBS9420883-04 5x 1 mg
Recombinant Clostridium botulinum Botulinum neurotoxin type A
Sign In for Pricing
View Details